These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17404719)

  • 41. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card Scheme.
    Krska J; Anderson C; Murphy E; Avery AJ
    Drug Saf; 2011 May; 34(5):429-36. PubMed ID: 21513365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse drug reaction reporting by nurses: analysis of Italian pharmacovigilance database.
    Conforti A; Opri S; D'Incau P; Sottosanti L; Moretti U; Ferrazin F; Leone R
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):597-602. PubMed ID: 22337264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knowledge attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital.
    Ergün Y; Ergün TB; Toker E; Ünal E; Akben M
    Int Health; 2019 May; 11(3):177-184. PubMed ID: 30265317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Public confidence in ADR identification and their views on ADRreporting: mixed methods study.
    Jarernsiripornkul N; Patsuree A; Krska J
    Eur J Clin Pharmacol; 2017 Feb; 73(2):223-231. PubMed ID: 27837337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adverse drug reactions reporting: pharmacists' knowledge, attitude and practice in Shiraz, Iran.
    Afifi S; Maharloui N; Peymani P; Namazi S; Gharaei AG; Jahani P; Lankarani KB
    Int J Risk Saf Med; 2014; 26(3):139-45. PubMed ID: 25214159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adverse drug reactions reporting: a questionnaire-based study on Egyptian pharmacists' attitudes following an awareness workshop.
    Alraie NA; Saad AA; Sabry NA; Farid SF
    J Eval Clin Pract; 2016 Jun; 22(3):349-55. PubMed ID: 26638825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district.
    Cosentino M; Leoni O; Banfi F; Lecchini S; Frigo G
    Pharmacol Res; 1997 Feb; 35(2):85-8. PubMed ID: 9175573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adverse drug reactions reporting by physicians in Ibadan, Nigeria.
    Okezie EO; Olufunmilayo F
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):517-22. PubMed ID: 18404621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issues.
    Hasford J; Bruchmann F; Lutz M; Thürmann P; Schmiedl S
    Eur J Clin Pharmacol; 2021 Nov; 77(11):1697-1704. PubMed ID: 34143228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Knowledge and attitudes to reporting adverse drug reactions.
    Pulford A; Malcolm W
    Br J Nurs; 2010 Jul 22-Aug 11; 19(14):899-904. PubMed ID: 20647982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reporting of adverse drug reactions by general practitioners: a questionnaire-based study in the Netherlands.
    Passier A; ten Napel M; van Grootheest K; van Puijenbroek E
    Drug Saf; 2009; 32(10):851-8. PubMed ID: 19722728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adverse drug reaction reporting related to the administration of antibiotics in hospitalized pediatric patients in Greece.
    Toska A; Mary G; Kyriakos S; Maria S; Costas D
    Curr Drug Saf; 2014 Mar; 9(1):49-55. PubMed ID: 24274669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database.
    Petronijevic M; Ilic K; Suzuki A
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):416-23. PubMed ID: 21370308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Adverse drug reaction reporting in emergency medicine].
    Milojevic K; Chassagnol I; Brion N; Cléro J; Degrèze N; Lambert Y
    Therapie; 2004; 59(6):611-4. PubMed ID: 15789824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nurses' reporting of suspect adverse drug reactions: a mixed-methods study.
    De Angelis A; Giusti A; Colaceci S; Vellone E; Alvaro R
    Ann Ist Super Sanita; 2015; 51(4):277-83. PubMed ID: 26783213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nurses' self-reported medication competence in relation to their pharmacovigilant activities in clinical practice.
    Johansson-Pajala RM; Martin L; Fastbom J; Jorsäter Blomgren K
    J Eval Clin Pract; 2015 Feb; 21(1):145-52. PubMed ID: 25327625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The spontaneous reporting of adverse drug reactions by nurses.
    Hall M; McCormack P; Arthurs N; Feely J
    Br J Clin Pharmacol; 1995 Aug; 40(2):173-5. PubMed ID: 8562303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.